To further investigate the role of the PI3K/mTOR pathway in shaping the TME in (u)LMS, we pursued tumour immune‐landscape mapping according to the six pan‐cancer immune landscapes identified by Torsson et al.35 The gene discussed is PIK3CB; the disease is cancer.